Henryk Domanski
71 – 80 of 105
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
(
- Contribution to journal › Article
-
Mark
Molecular cytogenetic characterization of recurrent translocation breakpoints in bizarre parosteal osteochondromatous proliferation (Nora's lesion).
(
- Contribution to journal › Article
-
Mark
Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
(
- Contribution to journal › Article
-
Mark
Retained heterodisomy for chromosome 12 in atypical lipomatous tumors: implications for ring chromosome formation.
(
- Contribution to journal › Article
-
Mark
Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
(
- Contribution to journal › Article
-
Mark
Matrix metalloproteinase-26 (Matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
(
- Contribution to journal › Article
-
Mark
Diagnosis and tumor response in osteosarcoma and Ewing's sarcoma
(
- Contribution to journal › Article
-
Mark
Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.
(
- Contribution to journal › Article
-
Mark
Immunohistochemical loss of the DNA mismatch repair proteins MSH2 and MSH6 in malignant fibrous histocytomas
(
- Contribution to journal › Article
-
Mark
Immunohistochemical Loss of the DNA Mismatch Repair Proteins MSH2 and MSH6 in Malignant Fibrous Histiocytomas.
(
- Contribution to journal › Article